Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Network Dynamics of the Immune System decodes Asthma Endotypes

ABSTRACT: Network Dynamics of the Immune System decodes Asthma Endotypes

PROVIDER: PRJNA840931 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Similar Datasets

Network Dynamics of the Immune System decodes Asthma Endotypes

Project description:The ‘Genetic Epidemiology of Asthma in Costa Rica’ is a family-based cross-sectional cohort ascertained between February 2001 and August 2008 on a Hispanic population isolate from the Central Valley of Costa Rica. The study recruited children between 6 to 14 years of age with moderate persistent asthma.

2022-05-21 | GSE203482 | GEO

Latent MicroRNA Networks in Asthma Endotypes [NS_H_miR_v3a]

Project description:Transcriptome analysis of whole blood from subjects with asthma and controls The presence or absence of type 2 inflammation (T2) biomarkers is used to identify T2-high and T2-low endotypes in the clinic. Despite the clinical relevance of these endotypes, the molecular mechanisms of T2-low asthma remain poorly understood. Specific microRNAs may regulate transcriptomic networks associated with asthma endotypes.

2025-12-01 | GSE287880 | GEO

Latent MicroRNA Networks in Asthma Endotypes [HuGene-1_0]

2025-12-01 | GSE287879 | GEO

Latent MicroRNA Networks in Asthma Endotypes [NS_H_miR_v3a]

Project description:Latent MicroRNA Networks in Asthma Endotypes [NS_H_miR_v3a]

| PRJNA1214851 | ENA

Latent MicroRNA Networks in Asthma Endotypes [HuGene-1_0]

Project description:Latent MicroRNA Networks in Asthma Endotypes [HuGene-1_0]

| PRJNA1214849 | ENA

qMAP decodes RNA fragmentation dynamics

Project description:qMAP decodes RNA fragmentation dynamics

| PRJNA1465826 | ENA

Gene signature profiles in whole blood cells from severe asthma patinets treated with benralizumab

Project description:Severe asthma is a clinically and physiologically heterogeneous disease. Benralizumab is a monoclonal antibody which binds the alpha chain of the interleukin-5 receptor and used for severe eosinophilic asthma worldwide. However, not all eosinophilic asthma patients will benefit from benralizumab due to heterogeneity of this disease. Therefore, we performed comprehensive gene expression analysis of whole blood cells that examine severe asthma disease heterogeneity in response to benralizumab. This study is the first to perform comprehensive transcriptome analysis of whole blood cells to identify transcriptomic endotypes of severe asthma clusters that correlate with benralizumab response. The identified transcriptomic endotypes of severe asthma clusters are associated with gene signatures of eosinophils and neutrophilis.

2023-04-15 | GSE148725 | GEO

Asthma Clinical Research Network IMProving Asthma Control Trial (ACRN-IMPACT-BioLINCC)

Project description:Asthma Clinical Research Network IMProving Asthma Control Trial (ACRN-IMPACT-BioLINCC)

| PRJNA1484143 | ENA

Asthma Clinical Research Network IMProving Asthma Control Trial (ACRN-IMPACT-BioLINCC)

Project description:Asthma Clinical Research Network IMProving Asthma Control Trial (ACRN-IMPACT-BioLINCC)

| PRJNA1484144 | ENA

Asthma Clinical Research Network Trial - Macrolides in Asthma (ACRN-MIA-BioLINCC)

Project description:Asthma Clinical Research Network Trial - Macrolides in Asthma (ACRN-MIA-BioLINCC)

| PRJNA1484145 | ENA